You have 9 free searches left this month | for more free features.

Androgen%20receptor

Showing 1 - 25 of 8,225

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer With or Without BRCA Mutation

Recruiting
  • Breast Cancer
  • Androgen receptor status and BRCA mutation
  • Varanasi, UP, India
    Banaras Hindu University
Jun 2, 2022

Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
  • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 4, 2023

Physical Function During ARSI Treatment

Recruiting
  • Advanced Prostate Carcinoma
  • androgen receptor signaling inhibitors
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 8, 2022

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

Not yet recruiting
  • Androgen Deprivation Therapy
  • +4 more
  • Gonadotropin-Releasing Hormone Agonist
  • +2 more
  • (no location specified)
Jan 18, 2023

Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

Active, not recruiting
  • Prostatic Neoplasms
  • Beijing, China
  • +3 more
Jan 17, 2023

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • Androgen Receptor Positive
  • Providence, Rhode Island
    Lifespan Cancer Institute
May 1, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 23, 2023

Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

Active, not recruiting
  • Androgen Receptor Positive
  • +5 more
  • Corona, California
  • +6 more
Jun 8, 2022

Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)

Recruiting
  • Salivary Gland Carcinoma
  • Chicago, Illinois
  • +6 more
Sep 22, 2022

Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Androgen deprivation therapy (ADT)
  • +3 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center Seidman Cancer Cen
Nov 21, 2023

Acne Vulgaris Trial in Stanford (Clascoterone 1% Top Cream, Vehicle)

Not yet recruiting
  • Acne Vulgaris
  • Stanford, California
    Stanford University
Jun 6, 2023

Breast Cancer Female, Triple Negative and Androgen Receptor Positive Trial in Caen (Darolutamide, Capecitabine)

Active, not recruiting
  • Breast Cancer Female
  • Triple Negative and Androgen Receptor Positive
  • Caen, France
    Centre François Baclesse
Jan 3, 2022

Androgen Receptor Polymorphism on Endometrial Cancer

Not yet recruiting
  • Androgen Receptor Abnormal
  • Endometrial Disorder
  • Endometrial sampling and Peripheral blood collection
  • FSFI Scale
  • (no location specified)
Dec 12, 2021

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Benjing, China
    • +2 more
    Dec 30, 2022

    Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

    Recruiting
    • Salivary Gland Cancer
    • Nagoya, Aichi, Japan
    • +11 more
    Jan 21, 2023

    Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Trastuzumab Deruxtecan
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jul 12, 2023

    Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)

    Recruiting
    • Breast Cancer
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin School of Medicine and Public Health
    Oct 18, 2022

    Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery

    Recruiting
    • Prostate Cancer
    • +6 more
    • Radiotherapy (SBRT) and/or surgery (metastasectomy)
    • +2 more
    • Leuven, Belgium
      University Hospitals Leuven
    Jun 7, 2022

    Prostate Cancer Trial in Baltimore (Flutamide, Placebo)

    Recruiting
    • Prostate Cancer
    • Baltimore, Maryland
      SKCCC at Johns Hopkins
    Sep 2, 2021

    Metastatic Breast Cancer Trial in United States (Orteronel)

    Completed
    • Metastatic Breast Cancer
    • New Haven, Connecticut
    • +9 more
    Jun 8, 2022

    Prostate Cancer Trial in Gainesville, Baltimore, Boston (LY2452473, Placebo)

    Completed
    • Prostate Cancer
    • Gainesville, Florida
    • +3 more
    Sep 27, 2021